Gender equality was supposed to reduce gender stratification and segregation in academic and professional pursuits. Instead, ...
Physicists in China have brought one of Einstein’s thought experiments into reality—but not quite with the outcome he hoped ...
The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases. By Gina Kolata Gina Kolata has ...
Abstract: This study presents an innovative design approach using a parallel interleaved winding structure to reduce parasitic effects in high-frequency PCB transformers. Among the solutions provided, ...
Parking is not always an easy task. Sometimes spots are too tight, too small or positioned strangely — not to mention the potential obstacles hindering your perfect parking, like other vehicles, trees ...
The leaders of the big three artificial-intelligence (AI) labs promise great things, and soon. Sam Altman, the boss of OpenAI, thinks next year computers will be capable of “novel insights”. Dario ...
Please provide your email address to receive an email when new articles are posted on . Data on medications and vaccines during pregnancy are limited. Vaccines and Medication in Pregnancy Safety ...
Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...
On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The company cited strategic ...
Following Federal Railroad Administration (FRA) approval in April and launch of Phase 1 in June, Parallel Systems, in partnership with Genesee & Wyoming (G&W), has transitioned to Phase 2 of its first ...
For the second time in the last three weeks, AbbVie has revealed successful results from a phase 3 study of Rinvoq as a treatment for the hair-loss disease alopecia areata (AA). The second replicate ...